Posted by Michael Wonder on 22 Aug 2025
Breakthrough life-extending combination treatment for advanced bladder cancer recommended by NICE
21 August 2025 - NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease.
Enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) is recommended for treating unresectable or metastatic urothelial cancer for people who are eligible for platinum‑containing chemotherapy.
